Company · CIK 0001434868 · SIC 2834 — Pharmaceutical Preparations
Esperion Therapeutics, Inc. · ESPR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 DForm 4 → | Jul 13, 4:06 pm EDT | Robert E. HoffmanDirector | 85,153 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | J Martin CarrollDirector | 177,523 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Jay ShepardDirector | 164,472 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Seth H. Z. FischerDirector | 141,023 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John Craig ThompsonDirector | 79,873 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John B. Harlow Jr.Chief Commercial Officer | 424,536 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | Benjamin LookerChief Legal Officer | 667,524 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Benjamin HalladayChief Financial Officer | 705,410 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Sheldon L. KoenigPresident and CEO, Director | 2,121,094 | — | — | 0 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 DForm 4 → | Jul 13, 4:06 pm EDT | Robert E. HoffmanDirector | 47,040 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | J Martin CarrollDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Jay ShepardDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:05 pm EDT | Seth H. Z. FischerDirector | 97,500 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | John Craig ThompsonDirector | 40,000 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:04 pm EDT | Benjamin LookerChief Legal Officer | 620,230 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Benjamin HalladayChief Financial Officer | 634,270 | — | — | 0 | — | |
| Jul 13, 2026 DForm 4 → | Jul 13, 4:03 pm EDT | Sheldon L. KoenigPresident and CEO, Director | 2,042,460 | — | — | 0 | — |